Using genetic polymorphisms of the BICD1 gene as a method for diagnosing and treating myopia
Using the BICD1 gene as a method for diagnosing myopia and/or myopia related complications is provided. The method includes obtaining a biological sample from a subject, and determining at least one SNP genotype in the BICD1 gene in the biological sample, wherein the presence of the SNP genotype indicates that the subject is susceptible to myopia. The SNP genotype is selected from the group consisting of SNPs rs7966276, rs1151029, rs2650122, and rs10771923. In addition, the present invention also provides a method of screening a material for preventing, treating myopia, and a method of assessing a subject for probability of response to a myopia therapeutic agent.
1. A method of determining an increased risk of developing myopia in a human, comprising detecting in a sample from the human the SNP rs7966276 (A/T) in the BICD1 gene, and determining the risk of developing myopia in the human, wherein the presence of the TT genotype is detected at the SNP rs7966276 (A/T) and indicates that the human has an increased risk of developing high myopia, and wherein the high myopia comprises a spherical refraction ≦−6 D.
2. The method as claimed in claim 1 , wherein the sample comprises blood, amniotic fluid, cerebrospinal fluid, tissue from skin, muscle, buccal or conjunctival mucosa, placenta, or gastrointestinal tract.